Philadelphia College of Osteopathic Medicine

DigitalCommons@PCOM
Scholarly Posters

2007

Herpes Simplex Virus 1 and Chlamydophila
(Chlamydia) pneumoniae promote Ab 1-42
amyloid processing in murine astrocytes linking an
infectious process to Alzheimer's disease
Laura R. Triplett
Philadelphia College of Osteopathic Medicine

Adam L. Dore
Philadelphia College of Osteopathic Medicine

Kevin S. Kralik
Philadelphia College of Osteopathic Medicine

Brian J. Balin
Philadelphia College of Osteopathic Medicine, brianba@pcom.edu

Susan T. Hingley
Philadelphia College of Osteopathic Medicine, susanh@pcom.edu
See next page
for and
additional
authors works at: http://digitalcommons.pcom.edu/posters
Follow
this
additional

Part of the Bacterial Infections and Mycoses Commons, Nervous System Diseases Commons,
and the Neurology Commons
Recommended Citation
Triplett, Laura R.; Dore, Adam L.; Kralik, Kevin S.; Balin, Brian J.; Hingley, Susan T.; and Appelt, Denah M., "Herpes Simplex Virus 1
and Chlamydophila (Chlamydia) pneumoniae promote Ab 1-42 amyloid processing in murine astrocytes linking an infectious process
to Alzheimer's disease" (2007). Scholarly Posters. Book 4.
http://digitalcommons.pcom.edu/posters/4

This Book is brought to you for free and open access by DigitalCommons@PCOM. It has been accepted for inclusion in Scholarly Posters by an
authorized administrator of DigitalCommons@PCOM. For more information, please contact library@pcom.edu.

Authors

Laura R. Triplett, Adam L. Dore, Kevin S. Kralik, Brian J. Balin, Susan T. Hingley, and Denah M. Appelt

This book is available at DigitalCommons@PCOM: http://digitalcommons.pcom.edu/posters/4

Herpes Simplex Virus 1 and Chlamydophila (Chlamydia) pneumoniae promote
Aβ 1-42 amyloid processing in murine astrocytes linking an infectious
process to Alzheimer's disease
Laura R. Triplett1, Adam L. Dore2, Kevin S. Kralik1, Brian J. Balin1, Susan T. Hingley1, Denah M. Appelt2.
Philadelphia College of Osteopathic Medicine, 1Pathology, Microbiology, Immunology and Forensic Medicine, 2Neuroscience, Pharmacology, and Physiology,
Center for Chronic Disorders of Aging

Background: Several studies have suggested an infectious etiology for Alzheimer's disease (AD).
Previously, our laboratory identified Chlamydia pneumoniae (Cpn) from autopsied sporadic AD
brains, as well as developed a BALB/c mouse model that demonstrated infection-induced amyloid plaques similar to those found in AD.
Hypothesis: We propose that an additional pathogen such as herpes simplex virus type 1
(HSV1), also may be a contributing factor in toin the pathology seen in AD. HSV1, in addition to Cpn, may be triggering the abnormal cleavage of the beta amyloid precursor protein
(βAPP) into Aβ1-42 , thereby contributing to amyloid plaque formation. Our current study
examines amyloid processing following infection of primary and C8-DIA murine astrocytes
with Cpn and HSV1.
Materials and Methods: Immunocytochemistry and western analysis was used to analyze the
outcome of infection by these two pathogens.
Results: Cpn infection resulted in an increase in cytoplasmic labeling of Aβ 1-42 relative to
uninfected cells, while increased nuclear labeling of Aβ 1-42 was observed following HSV1
infection. Co-infections with Cpn and HSV1 resulted in amyloid labeling resembling that of
HSV1 infection alone, though Aβ 1-42 labeling appeared decreased specifically in Cpn-infected cells of the co-infected monolayers.
Conclusions: These data suggest that infection of astrocytic cells by HSV1 and (Cpn) alter the
processing of βAPP, thereby producing Aβ1-42. Therefore, these studies, inaddition to the previous research reported by our laboratory, support an emerging linkage of the infectious processs
to the neuropathology characteristic of Alzheimer's disease.

Introduction
Amyloid plaques are a pathological feature of Alzheimer's disease (AD) that are formed by the
abnormal deposition of fragments of amyloid precursor protein (APP). Proteolysis by secretases
of APP near its carboxyl terminus leads to the generation of 40-43 amino acid peptides that
comprise Aβ (Selkoe et al., 1988). These peptides undergo conformational change into
β−sheets that deposit into plaques in regions of the brain particularly susceptible to this damage. This deposition appears to be critical in the neuronal degeneration observed in AD
(Schellenberg, 1995). There is a hereditary form of the disease, called Familial AD (FAD), that
accounts for a small percentage (~5%) of total AD cases world-wide, while sporadic AD
accounts for the vast majority of AD cases (estimates of 95% or more). Specific mutations have
been recognized in FAD that are associated with the increased proteolysis of APP to form Aβ.
However, with sporadic AD, other triggers for amyloid deposition must exist since no specific
genetic mutations have been recognized.
Infection within the central nervous system (CNS) by Cpn and HSV1. Cpn has been suggested to play a role in sporadic AD (see Itzhaki et al., 2004 for review). HSV1 is ubiquitous and
produces latent infection in neurons, with the potential for reactivation in the CNS. The chronic nature of this infection, with periodic reactivation of productive infection, may contribute to
the gradual accumulation of pathology associated with AD. In support of an association
between HSV1 infection and AD pathology, it has been shown that infection of human neuroblastoma cells produces a proteolytic fragment of APP that can be detected by Western blot
analysis (Dobson et al., 2002). Cpn has also been implicated as a potential pathogen contributing to events associated with AD. In two separate studies, polymerase chain reaction detected
Cpn DNA in 80 - 90% of postmortem brain samples examined from sporadic AD (Balin et al.,
1998, Gerard et al., 2006), but in only 5 - 11% of postmortem brain samples from age-matched,
non-AD, control individuals. Furthermore, a murine model has been developed in which nontransgenic mice infected with Cpndemonstrate deposits of amyloid in areas of the brain typically
affected in AD (Little et al., 2004).
The role that Cpn and/or HSV1 plays in “triggering” events resulting in AD pathology has been
further analyzed following in vitro infection of murine astrocyte cell line, C8-DIA. Experiments
were designed to determine whether infection with Cpn and HSV1, either singly or in combination, influences the production and/or processing of Aβ. Immunocytochemistry, using antibody specific for the 1-42 fragment of Aβ, suggested that infection in astrocytes with either
pathogen resulted in an increase in Aβ 1-42 immunoreactive peptides. Further analysis of Aβ 142 labeling has revealed immunoreactivity in both the cytoplasm and nucleus of cells infected
with the two pathogens. Cpn infection produced punctate labeling in the cytoplasm whereas
an HSV1 infection produced some punctate cytoplasmic labeling, but primarily aggregates of
label associated with cellular nuclei. These data suggest that infection in vitro promotes processing of the APP protein which may ultimately lead to the pathological accumulation of Aβ 1-42
consistent with that observed in Alzheimer's disease.

Results

Material & Methods
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Tissue Culture
The Vero cell line (ATCC CCL-81) were cultured in Eagle's Minimum Essential Medium
(MEM) containing non-essential amino acids and 10% heat-inactivated FBS. The C8-DIA
(ATCC CRL-2541) murine astrocyte cell line was cultured in Dulbecco's Modification of
Eagle's Medium (DMEM) containing 10% heat-inactivated fetal bovine serum (FBS). All cell
lines were maintained at 37°C in 5% CO2.
Infection of Cells
Chamber slides (4 wells/slide; SonicSeal; Nunc, Nalge) were seeded with approximately 2 x 105
cells. Within 24 hours of seeding the chamber slides, cell monolayers were infected with
Chlamydophila pneumoniae AR-39 (ATCC) and HSV1 at an MOI of 1. The pathogens were
allowed to attach for 60 min at 37ºC ,5% CO2, in growth medium and then the cells were
rinsed and incubated in 1ml of growth medium from 24 to 72 hours.
Viral Plaque Assay
HSV1 titers in culture supernates were measured by plaque assay. CCL-81 (ATCC) Vero cell
lineage from green African monkey kidneys were grown to confluency in 6-well plates.
Supernates were serially diluted in a buffered saline containing 0.17% gelatin and allowed to
attach to the Vero cells for 1 hour at 37º C, 5% CO2. After attachment, 3ml of a 1:1 mixture
of 1.4% agarose and 2X MEM growth medium was added to the infected monolayer. Once the
agarose solidified, 1ml of MEM was added to the wells. The plates were placed at 37º C, 5%
CO2, for 7 days. The agarose plugs were then removed, the monolayer was rinsed with distilled
water and stained with 1% neutral red. Viral plaques were counted and titers were
HSV1-4.2x105 PFV/ml and HSV1/Cpn-2.8x10. PFV/ml .
Immunofluorescence
Cells were grown in 4-well SonicSeal chamber slides. Following infection, the cells were rinsed
with HBSS and then fixed with cytofix/cytoperm (BD Bioscience) for 30 min at 4º C. The cells
were washed in phosphate buffer saline (PBS) and then blocked in cytoperm (BD
Bioscience)for 30 minutes at room temperature (RT). The slides were incubated with primary
antibodies (with or without a conjugated fluor) for 1 hour at 37º C, then washed in PBS.
Secondary antibodies (if required) were added to the slides and incubated for 1 hour at 37º C.
Following incubation, the slides were washed in PBS, followed by distilled water and then incubated at RT for 5 minutes with Bis-benzimide. The slides were coverslipped with anti-fading
aqueous mounting media (Biomeda).
Western Analysis
Cells were homogenized in lysis buffer (Sigma mammalian cells lysis kit; MCL-1) and electrophoresed into a 10-20% gradient Tris-HCL gel (Cat# 161-1160 Biorad) and transferred onto
0.45um_nitrocellulose (Schleicher & Schuell). The transfers were blocked in 3% blotto/PBS for
30 mins, incubated in primary antibody diluted in PBS for 2hrs at RT and then further blocked
in 1% blotto/PBS for 10 mins at RT followed by incubation in secondary antibody diluted in
1% blotto/PBS overnight at 4º C. The transfers were rinsed in PBS for 1hr and processed for
developing in ECL solutions (Santa Cruz).
Primary Antibody

Company

Dilution

Chlamydia 61C75 FITC
goat-anti-mouse

Fitzgerald

1:50

HSV1
goat-anti-mouse

Fitzgerald

1:1000

β-amyloid [1-42] (A 1976)
goat anti-rabbit

Sigma

1:250 & 1:500

Secondary Antibody

Company

Dilution

Alexa Fluor 594 Donkey
Anti goat

Molecular Probes

1:1000

Alexa Fluor 594 Goat
Anti Rabbit

Molecular Probes

1:1000

Alexa Fluor 488 Donkey
Anti Rabbit

Molecular Probes

Conclusions
●

Co-infection with C. pneumoniae does not alter HSV1 replication

●

C. pneumoniae infection of astrocytes was associated with increased cytoplasmic
labeling of β-1-42 amyloid

●

HSV1 infection of astrocytes was associated with increased nuclear labeling of
β-1-42 amyloid

1:500

Image Capture:
Slides were viewed on a Nikon E800 epifluorescence microscope . Images were captured with a
Spot RT camera (Diagnostic Instruments) and analyzed using Image Pro Plus 4.5 software
(Media Cybernetics).

●

●

Nuclear labeling of β-1-42 amyloid also was apparent in astrocytes co-infected with
C. pneumoniae and HSV1
β-1-42 amyloid appeared increased specifically in astrocytes co-infected with
C. pneumoniae and HSV1
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